Neurological manifestations in HTLV-I-infected blood donors

Journal of the Neurological Sciences

Volumn 214, Issue 1-2, 2003, Pages 49-56

  Leite, Ana C C ^a,b   Mendonça, Gulnar A S ^c   Andrada Serpa, Maria José ^a   Nascimento, Osvaldo J M ^d   Araújo, Abelardo Q C ^a  

^a HTLV   (Brazil)

^b HEMORIO   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Blood donors; HTLV I; HTLV I associated myelopathy; Motor neuron disease; Myopathy; Peripheral neuropathy

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DYSAUTONOMIA; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; MYOPATHY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; ORTHOSTATIC HYPOTENSION; PERIPHERAL NEUROPATHY; POLYMYOSITIS; POLYNEUROPATHY; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STATISTICAL ANALYSIS; VASCULITIS;

EID: 0042329577     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(03)00179-5     Document Type: Article

References (40)

1. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D.et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77:1980;7415-7419.
2. Manns A., Hisada M., La Grenade L. Human T-lymphotropic virus type I infection. Lancet. 353:1999;1951-1958.
3. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
4. Jeffery K.J., Siddiqui A.A., Bunce M., Lloyd A.L., Vine A.M.et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165:2000;7278-7284.
5. Yasui C., Fukaya T., Koizumi H., Kobayashi H., Ohkawara A. HTLV-I-associated myelopathy in a patient with adult T-cell leukemia. J. Am. Acad. Dermatol. 24:1991;633-637.
6. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H.et al. HTLV-I-associated myelopathy, a new clinical entity. Lancet. I:1986;1031-1032.
7. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. Blattner W. Human retrovirology: HTLV. 1990;191-197 Raven Press, New York.
8. World Health Organization Report of scientific group on HTLV-I infections and associated diseases. WHO Wkly. Epidemiol. Rec. 49:1989;382-383.
9. Cartier L., Araya F., Castillo J.L., Verdugo R., Mora C.et al. HTLV-I retrovirus in Chile: study on 140 neurological patients. Rev. Med. Chile. 118:1990;622-628.
10. Araujo A.Q.C., Ali A., Newell A., Dalgleish A.G., Rudge P. HTLV-I infection and neurological disease in Rio de Janeiro. J. Neurol. Neurosurg. Psychiatry. 55:1992;153-155.
11. Mora C.A., Garruto R.M., Brown P., Guiroy D., Morgan O.S.et al. Seroprevalence of antibodies to HTLV-I in patients with chronic neurological disorders other than tropical spastic paraparesis. Ann. Neurol. 23(Suppl.):1988;S192-S195.
12. Bhigjee A.I., Bill P.L., Wiley C.A., Windsor I.M., Matthias D.A.et al. Peripheral nerve lesions in HTLV-I-associated myelopathy (HAM/TSP). Muscle Nerve. 16:1993;21-26.
13. Kuroda Y., Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. J. Neurol. Sci. 106:1991;199-205.
14. Kira J., Fujihara K., Itoyama Y., Goto I., Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J. Neurol. Sci. 106:1991;41-49.
15. Kira J., Goto I., Otsuka M., Ichiya Y. Chronic progressive spinocerebellar syndrome associated with antibodies to human T-lymphotropic virus type I: clinico-virological and magnetic resonance imaging studies. J. Neurol. Sci. 115:1993;111-116.
16. Alamy A.H., Menezes F.B., Leite A.C., Nascimento O.M., Araujo A.Q. Dysautonomia in human T-cell lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis. Ann. Neurol. 50:2001;681-684.
17. Bartholomew C., Cleghorn F., Jack N., Edwards J., Blattner W. Human T-cell lymphotropic virus type I-associated facial nerve palsy in Trinidad and Tobago. Ann. Neurol. 41:1997;806-809.
18. Zunt J.R., Alarcon J.O., Montano S., Longstreth W.T. Jr., Price R.et al. Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection. Neurology. 53:1999;386-390.
19. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H.et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquired Immune Defic. Syndr. 3:1990;1096-1101.
20. Murphy E.L., Fridey J., Smith J.W., Engstrom J., Sacher R.A.et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology. 48:1997;315-320.
21. Kayembe K., Goubau P., Desmyter J., Vlietinck R., Carton H. A cluster of HTLV-I-associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J. Neurol. Neurosurg. Psychiatry. 53:1990;4-9.
22. Jeannel D., Garin B., Kazadi K., Singa L., de The G. The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire. J. Acquired Immune Defic. Syndr. 6:1993;840-844.
23. Center For Disease Control Licensure of screening tests for antibody to human T-lymphotropic virus type I. JAMA. 261:1989;515-520.
24. El Escorial Workshop World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124(Suppl.):1994; 96-107.
25. Ludolph A.C., Hugon J., Roman G.C., Spencer P.S., Schoenberg B.S. A clinical neurophysiologic study of tropical spastic paraparesis. Muscle Nerve. 11:1988;392-397.
26. Arimura K., Rosales R., Osame M., Igata A. Clinical electrophysiologic studies of HTLV-I-associated myelopathy. Arch. Neurol. 44:1987;609-621.
27. Levin M.C., Jacobson S. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J. Neurovirol. 3:1997;126-140.
28. Tajima K., Kamura S., Ito S., Ito M., Nagatomo M.et al. Epidemiological features of HTLV-I carriers and incidence of ATL in ATL-endemic island: a report of the community-based cooperative study in Tsushima, Japan. Int. J. Cancer. 40:1987;741-746.
29. Said G., Goulon-Goeau C., Lacroix C., Feve A., Descamps H.et al. Inflammatory lesions of peripheral nerve in a patient with HTLV-I-associated myelopathy. Ann. Neurol. 24:1988;275-277.
30. Vallat J.M., Dumas M., Grunitzky E.K., Akani F., Diop G.et al. Lack of association between peripheral neuropathy and HTLV-I infection in West Africa - epidemiological, serological and nerve biopsy study. J. Neurol. Sci. 119:1993;141-145.
31. Vernant J.C., Smadja D., Deforge-Lasseur C., Cabre P., Buisson G.et al. Vascularites et manifestations neurologiques liées au HTLV-I. Presse Med. 23:1994;1421-1425.
32. Nascimento O.J.M., De Freitas M.R.G., Araujo A.Q.-C., Escada T.M., Nevares M.T.et al. Peripheral neuropathy in human T lymphotropic virus type I-infected patients. Neurology. 46(Suppl. 45005):1996;A395. [Abstract].
33. Said G. Infective neuropathies. Curr. Opin. Neurol. 7:1994;398-401.
34. Dyck P.J., Karnes J., O'Brien P.C., Zimmerman I.R. Detection thresholds of cutaneous sensation in humans. Dyck P.J., Thomas P.K. Peripheral neuropathy. 1993;706-728 Saunders, Philadelphia.
35. Imamura A., Kitagawa T., Ohi Y., Osame M. Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy. Urol. Int. 46:1991;149-153.
36. Komine S., Yoshida K., Yamashita H., Masaki Z. Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Paraplegia. 27:1989;217-221.
37. Evans B.K., Gore I., Harrell L.E., Arnold T., Oh S.J. HTLV-I-associated myelopathy and polymyositis in a US native. Neurology. 39:1989;1572-1575.
38. Laraki R., Bletry O., Raguin G., Agbalika F., Bouche P.et al. Quatre nouvelles observations de neuromyosites, dont un cas associé à une infection par HTLV-I. Rev. Neurol. (Paris). 149:1993;283-288.
39. Rodgers-Johnson P., Morgan O.S., Mora C., Sarin P., Ceroni M.et al. The role of HTLV-I in tropical spastic paraparesis in Jamaica. Ann. Neurol. 23(Suppl.):1988;S 121-S 126. [Abstract].
40. Murphy E.L., Wilks R., Morgan O.S., Hanchard B., Cranston B.et al. Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort. Int. J. Epidemiol. 25:1996;1090-1097.